Lumenac C Effervescent Tablet Strawberry contains Acetylcysteine 600 mg, a mucolytic agent indicated for the management of respiratory conditions characterized by excessive or thickened mucus secretions. Acetylcysteine acts by breaking disulfide bonds in mucoproteins, thereby reducing the viscosity and elasticity of bronchial secretions, facilitating easier expectoration and improving airway clearance. This formulation is particularly beneficial in patients with chronic obstructive pulmonary disease (COPD), bronchitis, cystic fibrosis, and other pulmonary disorders where mucus retention impairs respiratory function. The effervescent tablet form, flavored with strawberry, enhances palatability and promotes patient compliance, especially in populations sensitive to taste or difficulty swallowing conventional tablets. Lumenac C is administered orally after dissolution in water, ensuring rapid onset of action and optimal bioavailability. It may also exhibit antioxidant properties, contributing to the reduction of oxidative stress in respiratory tissues. The recommended dosage and duration of treatment should be determined by a healthcare professional based on clinical assessment. Caution is advised in patients with hypersensitivity to acetylcysteine or related compounds. Adverse effects are generally mild and may include gastrointestinal discomfort or allergic reactions. Lumenac C Effervescent Tablet Strawberry is a valuable therapeutic option for improving mucus clearance and respiratory function in patients with mucus hypersecretion.